Sarcoma
Uterine Leiomyosarcoma (Sarcoma Part 1)
Sarcoma Trials
List of key sarcoma trials
GeDDiS: Gemcitabine and Docetaxel Versus Doxorubicin as First-Line Treatment in Advanced Soft-Tissue Sarcoma
Doxorubicin remains the standard first-line treatment for most patients with advanced soft-tissue sarcoma, as gemcitabine and docetaxel did not demonstrate superiority in survival outcomes